PHARMAPRINT Trademark
Trademark Overview
On Tuesday, October 8, 1996, a trademark application was filed for PHARMAPRINT with the United States Patent and Trademark Office. The USPTO has given the PHARMAPRINT trademark a serial number of 75178758. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, April 21, 2000. This trademark is owned by ABT Global Pharmaceutical Corp.. The PHARMAPRINT trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceuticals and pharmaceutical preparations based on natural medicines that-- reduce the symptoms of premenstrual stress (pms), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the resp...
General Information
Serial Number | 75178758 |
Word Mark | PHARMAPRINT |
Filing Date | Tuesday, October 8, 1996 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Friday, April 21, 2000 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 28, 1998 |
Trademark Statements
Goods and Services | pharmaceuticals and pharmaceutical preparations based on natural medicines that-- reduce the symptoms of premenstrual stress (pms), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the respiratory and urinary tracts; promote the flow in menstruation and reduce cramping pain; reduce certain types of skin outbreaks (eczema), reduce the pain of migraine headaches and menstrual periods, and are used in the treatment of asthma and arthritis; breakdown of blood clots; reduce nausea by acting on the digestive tract; and of abnormal changes in the light sensing portion of the eye, i.e., retina; reduce stress and damage caused to the liver; are used in the treatment of cancer; and are a general tonic; reduce cramping pain, muscle and joint pain; heart conditions associated with the elderly, mild heart pain brought on by exertion (angina), and mild irregularities of the heart beat; and lower blood pressure; are used in the treatment of degenerative arthritis; reduce distress of the intestinal tract; and improve the clearing of mucus from the lungs; cause sleepiness and treats insomnia; are used in the treatment of ulcers and arthritis; reduce inflammation; and improve the clearing of mucus from the lungs; protect the liver, including against scarring (cirrhosis) and inflammation (hepatitis); are a free radical scavenger and antioxidant; reduce pain and inflammation and improve insomnia and bronchial asthma; are used in the treatment of cancer and diabetes; and in some ways act like an antioxidant; have an effect against cancer; lower blood pressure; help protect a developing fetus against damage from exposure of drugs, chemicals and certain other materials; help the body remove excess fluid through urination; are used in the treatment of asthma; improve rheumatism; and stimulate the growth of hair; promote sleepiness; calm; modify the activity of the body's immune system; and reduce elevated levels of certain fatty substances in the blood; treat cancer |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, October 31, 1996 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | PHARMAPRINT INC. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Irvine, CA 92714 |
Party Name | PHARMAPRINT INC. |
Party Type | 11 - New Owner Before Publication |
Legal Entity Type | 03 - Corporation |
Address | Irvine, CA 92612 |
Party Name | ABT Global Pharmaceutical Corp. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Irvine, CA 92714 |
Trademark Events
Event Date | Event Description |
Friday, August 2, 2002 | PAPER RECEIVED |
Tuesday, April 17, 2001 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, August 29, 2000 | DIVISIONAL PROCESSING COMPLETE |
Wednesday, April 19, 2000 | DIVISIONAL REQUEST RECEIVED |
Monday, December 6, 1999 | EXTENSION 2 GRANTED |
Tuesday, October 19, 1999 | EXTENSION 2 FILED |
Thursday, June 3, 1999 | EXTENSION 1 GRANTED |
Monday, April 19, 1999 | EXTENSION 1 FILED |
Tuesday, October 20, 1998 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, July 28, 1998 | PUBLISHED FOR OPPOSITION |
Friday, June 26, 1998 | NOTICE OF PUBLICATION |
Tuesday, May 12, 1998 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, June 19, 1997 | NON-FINAL ACTION MAILED |
Friday, April 11, 1997 | ASSIGNED TO EXAMINER |